Diagnos Laboratorium Utama Tbk. vs Sat Nusapersada Tbk — how do they compare? Diagnos Laboratorium Utama Tbk. trades at Rp224 (market cap 310.75B, 963.6K 24h volume), while Sat Nusapersada Tbk trades at Rp244 (market cap 1.29T, 620.7K 24h volume). The key difference: Sat Nusapersada Tbk is far larger — about 4.2× Diagnos Laboratorium Utama Tbk.'s market cap, and Diagnos Laboratorium Utama Tbk. is more actively traded (963.6K versus 620.7K). Which is the better fit depends on your goals.
| DGNS | PTSN | |
|---|---|---|
Market Cap | 310.75B | 1.29T |
Volume | 963.6K | 620.7K |
Lot | 9.64K | 6.21K |
Turnover | 217.67M | 151.23M |
Average Price | 225.89 | 243.64 |
Value | 217.67M | 151.23M |
Indicative Equilibrium Price | 226 | 244 |
Indicative Equilibrium Volume | 1K | 15 |
Trailing returns across standard periods
Latest headlines on both assets
PT Diagnos Laboratorium Utama Tbk (the “Company”) was established in the Republic of Indonesia on August 29, 2007 under framework of the Domestic Capital Investment Law No. 6 Year 1968 based on Deed No.17 dated August 29, 2007, of Martinef, S.H., M.Si., Notary in Bekasi. The Company started its commercial operation in 2008.
Read more on DGNS →Sat Nusapersada Tbk (the company) was established on Jun 1, 1990 based on Notaries Deed No. 5 and the deed of establishment was approved by the the Ministry of Justice dated Sept 18, 1991. The Company’s articles of association has been amended several times, most recently by notarial deed No. 14 of Fathiah Helmi, S.H., dated Aug 7, 2007, concerning public offering.
Read more on PTSN →